Bristol-Myers Squibb Company
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

Abstract:

The present invention provides compounds of Formula (Ia) and (Ib): (Ia) or (Ib), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors. ##STR00001##